UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 227

Sortiert nach

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients

Clinical colorectal cancer, 2021-06, Vol.20 (2), p.130-136

2021

Volltextzugriff (PDF)

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

Journal of clinical oncology, 2015-11, Vol.33 (32), p.3733-3740

2015

Volltextzugriff (PDF)

Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection

Annals of surgical oncology, 2003-04, Vol.10 (3), p.213-218

2003

Volltextzugriff (PDF)

Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective

Mayo Clinic proceedings, 2012-05, Vol.87 (5), p.424-429

2012

Volltextzugriff (PDF)

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

Journal of clinical oncology, 2016-03, Vol.34 (8), p.843-853

2016

Volltextzugriff (PDF)

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.400-407

2021

Volltextzugriff (PDF)

Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials

Journal of clinical oncology, 2023-02, Vol.41 (4), p.803-815

2023

Volltextzugriff (PDF)

Targeted therapy for metastatic colorectal cancer

Expert review of anticancer therapy, 2018-10, Vol.18 (10), p.991-1006

2018

Volltextzugriff (PDF)

Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic Disease

The oncologist (Dayton, Ohio), 2009-10, Vol.14 (10), p.963-969

2009

Volltextzugriff (PDF)

Primary Chemoradiotherapy for Older Patients With Esophageal Cancer

JAMA oncology, 2021-10, Vol.7 (10), p.1451

2021

Volltextzugriff (PDF)

Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)

Pharmacogenetics and genomics, 2021-12, Vol.31 (9), p.215

2021

Volltextzugriff (PDF)

Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2325-2331

2005

Volltextzugriff (PDF)

Phase I Study of Preoperative Radiation Therapy With Concurrent Infusional 5-Fluorouracil and Oxaliplatin Followed by Surgery and Postoperative 5-Fluorouracil Plus Leucovorin for T3/T4 Rectal Adenocarcinoma: ECOG E1297

International journal of radiation oncology, biology, physics, 2008-09, Vol.72 (1), p.108-113

2008

Volltextzugriff (PDF)

Long term survival after pancreatic resection for pancreatic adenocarcinoma

The American journal of gastroenterology, 2001-09, Vol.96 (9), p.2609-2615

2001

Volltextzugriff (PDF)

Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database

Journal of clinical oncology, 2016-04, Vol.34 (11), p.1182-1189

2016

Volltextzugriff (PDF)

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer

American journal of clinical oncology, 2018-12, Vol.41 (12), p.1193-1198

2018

Volltextzugriff (PDF)

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)

The oncologist (Dayton, Ohio), 2020-05, Vol.25 (5), p.e798-e807

2020

Volltextzugriff (PDF)

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

The New England journal of medicine, 1990-02, Vol.322 (6), p.352-358

1990

Volltextzugriff (PDF)

Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019

Expert review of anticancer therapy, 2020-04, Vol.20 (4), p.251-270

2020

Volltextzugriff (PDF)

Bevacizumab beyond progression: does this make sense?

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5313-5315

2008

Volltextzugriff (PDF)

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis

Expert review of anticancer therapy, 2018-04, Vol.18 (4), p.339-349

2018

Volltextzugriff (PDF)

A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282

International journal of radiation oncology, biology, physics, 2005-08, Vol.62 (5), p.1345-1350

2005

Volltextzugriff (PDF)

New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference

Clinical cancer research, 2007-11, Vol.13 (22), p.6853s-6856s

2007

Volltextzugriff (PDF)

Treatment sequence of synchronously (liver) metastasized colon cancer

Digestive and liver disease, 2016-10, Vol.48 (10), p.1119-1123

2016

Volltextzugriff (PDF)

1 – 25 von 227

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(130)
Life Sciences & Biomedicine
(113)
Humans
(95)
Oncology
(74)
Female
(43)
Male
(39)
Middle Aged
(29)
Aged
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Adult
(20)
Neoplasm Staging
(18)
Treatment Outcome
(17)
Chemotherapy
(16)
Colorectal Neoplasms - Drug Therapy
(16)
Colorectal Neoplasms - Pathology
(16)
Combined Modality Therapy
(16)
Colorectal Cancer
(15)
Prognosis
(15)
Fluorouracil - Administration & Dosage
(14)
Chemotherapy, Adjuvant
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection

Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research: A Joint Journal and Pharmaceutical Industry Perspective

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)

Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials

Targeted therapy for metastatic colorectal cancer

Resection of the Primary Colorectal Cancer Is Not Necessary in Nonobstructed Patients with Metastatic Disease

Primary Chemoradiotherapy for Older Patients With Esophageal Cancer

Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)

Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus

Phase I Study of Preoperative Radiation Therapy With Concurrent Infusional 5-Fluorouracil and Oxaliplatin Followed by Surgery and Postoperative 5-Fluorouracil Plus Leucovorin for T3/T4 Rectal Adenocarcinoma: ECOG E1297

Long term survival after pancreatic resection for pancreatic adenocarcinoma

Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019

Bevacizumab beyond progression: does this make sense?

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis

A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282

New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference

Treatment sequence of synchronously (liver) metastasized colon cancer

Aktive Filter

Suchergebnisse filtern